The discovery that specific bacterial toxins create identifiable mutational signatures in human colorectal cancer genomes represents a paradigm shift in understanding how our microbiome directly shapes disease at the genetic level. This finding transforms colorectal cancer from a primarily genetic disease into what researchers now recognize as an ecosystem disorder orchestrated by microbial communities.
The research identifies three key bacterial culprits: Fusobacterium nucleatum, toxin-producing E. coli strains, and enterotoxigenic Bacteroides fragilis. These pathogenic microbes produce genotoxins including colibactin and cytolethal distending toxin that directly damage DNA while simultaneously dismantling the intestinal barrier and hijacking immune responses. Meanwhile, protective bacteria that produce short-chain fatty acids—natural anti-inflammatory compounds—become depleted, removing crucial metabolic defenses against tumor development.
This mechanistic understanding positions colorectal cancer within a broader framework of microbiome-mediated diseases affecting longevity. The concept of 'biofilm-structured ecosystem disease' suggests that coordinated microbial consortia, rather than individual pathogens, drive carcinogenesis through synchronized metabolic cooperation and immune evasion. The identification of specific mutational fingerprints from bacterial metabolites provides unprecedented evidence for direct microbe-to-genome causality in human cancer. While this review synthesizes existing research rather than presenting new clinical data, it establishes the scientific foundation for microbiota-targeted cancer prevention strategies. For health-conscious adults, this research underscores how gut health interventions—from dietary fiber to targeted probiotics—may serve as powerful tools for cancer prevention by maintaining protective microbial communities.